pharmather

This Week in Psychedelics - 1.7.22

Cannabis

  • Sadiq Khan plans pilot to ‘decriminalise’ minor cannabis offences in London (The Guardian)

  • Legal recreational marijuana sales begin in Montana (KPAX)

  • Federal Marijuana Monopoly Finally Ends As Two Companies Harvest Cannabis Approved By DEA (Marijuana Moment)

  • New year rings in key changes to state marijuana markets (Marijuana Business Daily)

  • GOP-Controlled New Hampshire House Votes To Legalize Marijuana Possession And Cultivation (Marijuana Moment)

  • Colorado: Governor Issues Pardons to Over 1,300 Marijuana Offenders (NORML)

  • Wyoming Marijuana Activists Turn Focus To 2024 Ballot For Decriminalization And Medical Cannabis Initiatives (Marijuana Moment)

  • The top cannabis research studies of 2021 (Leafly)

  • Incoming Virginia GOP Governor Won’t ‘Overturn’ Legal Marijuana Possession, But Casts Doubt On Sales (Marijuana Moment)

  • Top Kansas Democrats Unveil Plan To Put Medical And Adult-Use Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

  • Two recreational marijuana initiatives might appear on Oklahoma ballot in fall (Marijuana Business Daily)

  • Iowa Democrats Unveil Marijuana Resolution To Put Legalization On Ballot For Voters To Decide (Marijuana Moment)

  • New Republican-Led Bill Would Legalize Medical Cannabis In Kentucky (Marijuana Moment)

  • South Dakota Lawmakers Prepare Dozens Of Cannabis Reform Bills (High Times)

  • Marijuana Decriminalization Reduces Arrests And Racial Disparities In Law Enforcement, Study Finds (Marijuana Moment)

  • Tiny but mighty: Micro-cultivators dominated 2021 (Leafly)

  • The cost of medical marijuana in Louisiana (KSLA)

  • Israeli startup a go-to resource in medical cannabis world (I24News)

  • Oklahoma Pot Farm Slapped with RICO From Next Door Neighbor (High Times)

  • Cannabis users report higher quality of life than non-users (Leafie)

Magic Mushrooms

  • Washington Psilocybin Bill Would Legalize Supported Adult Use (Bill of Health)

  • COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology (Psilocybin Alpha)

  • New Hampshire Bipartisan Bills Want to Reduce Penalties on Psilocybin, Other Drugs (Truffle Report)

  • Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder (Psilocybin Alpha)

  • Filament Health Announces Health Canada Approval for Phase II Trial Administering New Psilocybin Microdose Formulation (Psilocybin Alpha)

  • Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

  • Psilocybin therapy options could expand in Hawaiʻi (Hawai'i Public Radio)

MDMA

  • Drug testing: Dramatic drop in bath salts being sold as MDMA (Radio New Zealand)

  • Microdosing MDMA: What Research Says About Doing It For Mental Health Issues (Healing Maps)

DMT

  • Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee (Psilocybin Alpha)

Ayahuasca

  • IRS defends denial of Des Moines church's tax-free status over use of psychedelic drug (KCCI)

  • Anti-Drug GOP Senator Helps Psychedelic Church With Fight Against DEA And IRS (Marijuana Moment)

Iboga

  • National Institute on Drug Abuse to Test Ibogaine For Addiction Treatment (Truffle Report)

  • Caribbean Facility Finds Consistent Success Using Ibogaine for Anxiety and Trauma Treatment (PR Newswire)

Novel Psychoactive Substances

  • MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC (Psilocybin Alpha)

  • Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds (Psychedelic Spotlight)

Synthetic Cannabinoids

  • Using cannabinoids to treat obesity (Medical Xpress)

  • More needs to be done to tackle synthetic cannabinoids, experts say (Stuff.co.nz)

Ketamine

  • Awakn Life Sciences Expands World's First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral Addictions (Yahoo!)

  • PharmaTher Announces Publication of Research Data for KETABET™ (Psilocybin Alpha)

Miscellaneous

  • The Promises and Perils of Psychedelic Health Care (The New York Times)

  • Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy (Psychedelic Spotlight)

  • Magic mushroom companies are on the Nasdaq now. That’s a recipe for a bad trip (The Guardian)

  • Psychedelics Can Change Your View on the Nature of Reality (Psychedelic Spotlight)

  • Psychedelics in 2022: What to Expect (Truffle Report)

  • Fact Check-London Mayor not decriminalising drugs (Reuters)

  • Psychedelics 2021: A Year in Review (Psilocybin Alpha)

  • Will overdose deaths force an end to the US ‘war on drugs’? (Financial Times)

  • Philippines' Duterte says will never apologise for drug war deaths (Reuters)

  • New York Prisons Punished 1,600 People for False Drug Test Results (Filter)

  • Now psychedelics are coming to your medicine cabinet (ISRAEL21c)

  • How Psychedelic Therapy Fuses Indigenous Shamanism With Western Science (IFLScience)

  • Pop Culture Boosts Acceptance of Plant Medicine (GlobeNewswire)

  • Can A Psychedelic Experience Improve 2022? (Reality Sandwich)

  • Psychedelic Drug Policy Reform in 2021: A Year in Review (Psilocybin Alpha)

  • Psychedelics Will Have a Big Presence at SXSW in 2022 (Psychedelic Spotlight)

  • Was 2021 the Year Psychedelics Conquered Capitalism? (Green Entrepreneur)

  • Startup To Host Psychedelic Trips In The Metaverse (Forbes)

  • Is ‘The Trip’ Essential to The Psychedelic Experience? (Psychedelic Spotlight)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.17.21

Cannabis

  • Malta becomes first EU country to legalise cannabis for personal use (Euronews)

  • St. Louis Mayor Signs Bill To Decriminalize Marijuana Possession And Cultivation (Marijuana Moment)

  • No Fentanyl Found in Cannabis After All, Vermont Police Say (High Times)

  • Viral story shared across social media about two teens overdosing on fentanyl-laced marijuana in Springfield was untrue (MassLive)

  • Ministry pushes full cannabis legalisation (Bangkok Post)

  • Government-Funded Study Shows Unprecedented Decline in Marijuana Use By Young People (NORML)

  • Pfizer to Acquire Pharmaceutical Company Testing Cannabinoid Treatment (High Times)

  • Heavy metals in cannabis plants could affect human health, study finds (New Atlas)

  • Rhode Island Legalization Bill Set for Early 2022 Introduction (High Times)

  • Baltimore: City Officials Move to Abolish Pre-Employment Drug Screens for Many Public Employees (NORML)

  • Smoking CBD-Rich Marijuana Has ‘No Significant Impact’ On Driving Ability, Study Finds (Marijuana Moment)

  • Cannabis use could cause harmful drug interactions (ScienceDaily)

LSD

  • Cary Grant Is High on LSD in ‘Flying Over Sunset.’ Everyone Else Has a Bad Trip. (The Daily Beast)

  • PharmaTher Announces Positive Research Results for LSD Microneedle Patch (BioSpace)

  • MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD (Psilocybin Alpha)

Magic Mushrooms

  • New Filing Challenges Compass Pathways’ Infamous Patent on Synthetic Psilocybin (VICE)

  • Psilocybin-assisted psychotherapy reduces loss of meaning and suicidal ideation among cancer patients (PsyPost)

  • With health care workers hurting, a doctor wants to see if a psychedelic can help (NBC News)

  • COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants in open-label treatment-resistant depression study (Psilocybin Alpha)

  • More patients granted psilocybin exemption by federal government (CBC)

  • Warning: Oregon Legalized Supported Adult Use of Psilocybin, Not Psychedelic Therapy (Chacruna)

  • New York Lawmaker Files Bill To Legalize Medical Psilocybin Treatments, With Focus On First Responders And Veterans (Marijuana Moment)

  • This Trippy New Book Takes You Through Modern Mushroom History—With Cartoons (DoubleBlind)

  • Psyched Wellness Announces Path to Market for AME-1-derived Products in the USA (Psilocybin Alpha)

  • Silo Wellness announces series of psilocybin retreats in Jamaica (Globetrender)

  • HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes (Psilocybin Alpha)

MDMA

  • The Big Return – and Decline in Quality – of MDMA (VICE)

  • Latest trials confirm the benefits of MDMA – the drug in ecstasy – for treating PTSD (The Conversation)

  • MDMA could soon be used to treat PTSD according to physicians (Mixmag)

Ayahuasca

  • Study links the ceremonial use of ayahuasca to robust reductions in neuroticism (PsyPost)

  • Educating Gringos in Shipibo Ways (Chacruna)

  • Esther Jean Langdon: Half a Century of Research About Shamanism and Ayahuasca (Chacruna)

Novel Psychoactive Substances

  • Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine) for the Treatment of Anxiety Disorders (Psilocybin Alpha)

  • atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 in Cognitive Impairment Associated with Schizophrenia (Psilocybin Alpha)

Synthetic Cannabinoids

  • Tainted synthetic marijuana linked to severe bleeding cases in Florida (Live Science)

Miscellaneous

  • Psychedelics Rejected for Therapeutic Use in Australia (VICE)

  • Can a Values-Centered Psychedelic Ecosystem Effectively Compete? (Lucid News)

  • Mind Medicine Australia’s Response to the Announcement of the TGA NOT to Reschedule the Medical Use of MDMA for Treatment Resistant PTSD and the Medical Use of Psilocybin for Treatment Resistant Depression as Part of Therapy. (Mind Medicine Australia)

  • How Do Psychedelics Change Your Personality? These Researchers Tried To Find Out (IFLScience)

  • ‘This isn’t the 60s again’: psychedelics business takes off amid culture clash (The Guardian)

  • 2022 Global Drug Survey: Help make it bigger than ever for its 10 year anniversary (TalkingDrugs)

  • Most Addiction Specialists Support Legalized Therapeutic Psychedelics (Medscape)

  • Psychedelic-Assisted Therapy on the Rise in VA Hospitals (Lucid News)

  • Psychedelics and Substance Use Disorder: 4000 BCE to Present Day (Psychedelic Science Review)

  • Many Indians Are Experimenting With Psychedelics, Other Drugs to Deal With Mental Health Issues (The Swaddle)

  • Editor’s Choice Award 2021-Best Study on Psychedelics and Neuroplasticity (Psychedelic Science Review)

  • atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with Massachusetts General Hospital’s Center for the Neuroscience of Psychedelics (Psilocybin Alpha)

  • How to Start Microdosing Psychedelics (DoubleBlind)

  • Understanding HPPD to Prioritize Harm Reduction of a Very Real Psychedelic Risk (Psychedelic Spotlight)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.3.21

Cannabis

  • Home of Dubai, the United Arab Emirates, Ends Jail Time for Travelers with THC (High Times)

  • Mexico has a new marijuana legalization bill. Here’s what’s in it (Leafly)

  • Reps. Dave Joyce and Alexandria Ocasio-Cortez Introduce Legislation To Expunge Marijuana Records (NORML)

  • South Dakota's Governor Succeeds in Blocking Voter-Approved Marijuana Legalization (Reason)

  • Fentanyl-laced vape pens among teens concern after Tennessee high school incident (WKYT)

  • Record Number of Scientific Papers Published About Cannabis in 2021 (NORML)

  • Death sentences upheld for two men convicted of cannabis trafficking (Singapore Law Watch)

  • California rolls out plans to standardize cannabis testing statewide (Marijuana Business Daily)

  • Jamaican Government Launches ‘Good Ganja Sense’ Campaign To Debunk Marijuana Myths (Marijuana Moment)

  • Great News, Scientists Finally Figured Out Why Cannabis Smells 'Skunky' (ScienceAlert)

  • Texas Activists Turn In Signatures To Put Marijuana Decriminalization On Austin’s 2022 Ballot (Marijuana Moment)

  • Kentucky Lawmaker Pre-Files Marijuana Legalization Bills For 2022 Session (Marijuana Moment)

  • Colorado University Announces Groundbreaking Study on Cannabis and Exercise (High Times)

  • Massachusetts: Majority of Adults Say Marijuana Legalization Has Been “Positive” for the State (NORML)

LSD

  • Blotter paper should be included while measuring weight of LSD, rules Bombay HC (India Today)

  • How LSD changed The Beatles forever (Far Out Magazine)

Magic Mushrooms

  • New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression (Psychedelic Spotlight)

  • Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress (Psilocybin Alpha)

  • U of M Medical School launches new mechanistic study of psilocybin (University of Minnesota)

Ayahuasca

  • Sexual Assault in the Amazon (The Cut)

Iboga

Novel Psychoactive Substances

  • MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation (Psilocybin Alpha)

  • Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases (Psilocybin Alpha)

Nitrous Oxide

  • ‘Everyone’s gagging for it’ – how Britain got high on nitrous oxide (The Guardian)

  • Dozens of traffic accident deaths linked to laughing gas use (NL Times)

Ketamine

  • Ketamine review: Chemical restraints may have been ‘disproportionately’ used on ‘communities of color’ (KDVR)

  • As ketamine clinics emerge in Seattle to treat mental illness, so does debate about safety and regulations (The Seattle Times)

  • PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio (Psilocybin Alpha)

Miscellaneous

  • New York City Opens First Safe Consumption Sites For Illegal Drugs In The U.S. (Marijuana Moment)

  • Florida Lawmaker Files Bill To Decriminalize All Currently Illicit Drugs (Marijuana Moment)

  • Toronto May Be the Next City to Decriminalize Psychedelics and Other Drugs (Truffle Report)

  • Study Shows People Who Use Psychedelics Were Under Less Stress During Covid-19 Lockdowns (Forbes)

  • DEA Again Boosts 2022 Production Goals For Psychedelics Like Psilocybin, MDMA and DMT (Marijuana Moment)

  • People ‘microdosing’ psychedelics to improve wellbeing during pandemic, drug survey finds (The Independent)

  • Psychedelics may have long-term impact treating depression, mental illness - study (The Jerusalem Post)

  • Psychedelic Telemedicine Has Arrived. What Could Possibly Go Wrong? (VICE)

  • The Psychedelic Renaissance Is Ushering In a New Genre Of Electronic Music — And With It, New Revenue Streams (Billboard)

  • Holiday Gift Guide 2021: Gifts For The Psychedelic Explorer (Forbes)

  • Can ethics and sexual abuse allegations create backlash and impact the current psychedelic renaissance? (Chacruna)

  • Will the psychedelic revolution bypass people of color? (The Lens)

  • Celebrities: Are They Helping or Harming the Psychedelic Movement? (Psychedelic Spotlight)

  • Origin Therapeutics Portfolio Company Tripsitter has Commenced Trading on the Canadian Securities Exchange (GlobeNewswire)

  • Peter Thiel-backed psychedelic start-up increases stake in Compass Pathways (CNBC)

  • Microdosing Protocols: Microdosing Every Day vs. Every Other Day (DoubleBlind)

  • Editor’s Choice Award 2021-Best Study on Psychedelics and Neurochemistry (Psychedelic Science Review)

  • Novel Psychedelic Treatment Approach Bypasses Hallucinogenic Effects to Allow Widespread Adoption (Pharmacy Times)

  • Israeli start up makes pharmaceuticals out of psychedelic flora (i24 News)

  • Getting Ahead of the Psychedelics Supply Crunch (Truffle Report)

  • Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.26.21

Cannabis

  • The new German government plans to legalize cannabis. (The New York Times)

  • Mexico Senate on Track to Endorse Recreational Cannabis by December (High Times)

  • Uber Eats users in Ontario can now buy cannabis through the app (Engadget)

  • New GOP weed approach: Feds must ‘get out of the way’ (Politico)

  • South Dakota Supreme Court kills adult-use legalization (Leafly)

  • Is Fentanyl-Tainted Marijuana 'Something Real' or 'Just an Urban Legend'? (Reason)

  • A New Center at CSU Aims to Unlock the Secrets of CBD (5280)

  • Indica and sativa labels are largely meaningless when it comes to cannabis complexities (The Conversation)

  • St. Louis Lawmakers Unanimously Approve Bill To Decriminalize Marijuana Possession And Cultivation (Marijuana Moment)

  • Analysis: Marijuana Legalization Associated with Improved Clearance Rates for Violent Crimes (NORML)

  • Illinois Judge Rules Weed Odor is Not Probable Cause For Searches (High Times)

  • Ohio Marijuana Activists Almost Have Enough Signatures To Force Lawmakers To Consider Legalization (Marijuana Moment)

  • New Mexico Issues First Adult-Use Cannabis Cultivation License (High Times)

  • Taliban Contracts Australian Company To Grow Cannabis In Afghanistan (Marijuana Moment)

  • Mississippi lawmakers unlikely to reach medical marijuana deal this year (Marijuana Business Daily)

  • Dogs Are Being Exposed To Marijuana Through Human Poop And Pet Owners Should Beware, Study Finds (Marijuana Moment)

  • Majority Of Texas Republicans Back Marijuana Legalization, Poll Finds (Marijuana Moment)

  • Arizona Cannabis Social Equity Program Faces Legal Challenge (High Times)

  • Canada’s first regulated cannabis suppositories target female consumers (Marijuana Business Daily)

  • Montana: Officials Create New Drug Court to Focus Solely on Expunging Past Marijuana Convictions (NORML)

  • Few Medical Cannabis Licenses in Portugal Have Been Awarded (High Times)

  • Pennsylvania order targeting vaporized products upends cannabis market (Marijuana Business Daily)

  • CNN’s Sixth WEED Documentary Features the Benefits of Medical Cannabis for Autism (High Times)

LSD

  • New graphic novel depicts famed history of LSD research in Sask. (CBC)

Magic Mushrooms

  • Magic mushroom study hints psilocybin repairs alcohol-induced brain damage (Inverse)

  • COMPASS Pathways granted fifth US patent for crystalline psilocybin (Psilocybin Alpha)

  • Metaphysics and mushrooms: Psychedelics can change how you think about the universe (Big Think)

  • What Happens When Zen Monks Take Mushrooms? (Lucid News)

  • HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada (Psilocybin Alpha)

MDMA

  • Police Presence at Music Festivals Linked to "Panic Overdoses": Study (EDM)

DMT

  • Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs (Psilocybin Alpha)

Ayahuasca

  • Ayahuasca users report psychological benefits after taking placebo at a ritualistic ceremony (PsyPost)

  • Are All Ayahuasca Retreats The Same? You Might Be Surprised (Healing Maps)

Peyote

  • Mining and Poaching Threatens 15,000-Year-Old Peyote Tradition in Mexico (DoubleBlind)

San Pedro

  • San Pedro: What is it Like to Experience Mescaline from San Pedro? (The Third Wave)

Novel Psychoactive Substances

Ketamine

  • Ketamine benefits neurocognition in depression with suicidal ideation (Healio)

  • Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments (Psilocybin Alpha)

  • PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus (Psilocybin Alpha)

  • Navigating the Patchwork of New York City Ketamine Clinics (Lucid News)

Miscellaneous

  • New Zealand Permanently Legalizes Drug Checking, a Global First (Filter)

  • U.S. Reports More Than 100,000 Overdose Deaths In One Year (High Times)

  • New study finds 'microdosing' psychedelics can be effective in treating anxiety, depression (The Hill)

  • Responding to the 2022 Global Drug Survey Will Help Other Drug Users (Filter)

  • Colorado Springs Pushing to Decriminalize Psychedelics (Truffle Report)

  • The Rise of Psychedelic Retreats (The New York Times)

  • How to Cultivate a More Ethical, Inclusive Psychedelic Future (Lucid News)

  • Why Are Some People More Sensitive to Psychedelics Than Others? (Sam Woolfe)

  • Cybin Awards Grant for Psychedelic Treatment Clinic at Lenox Hill Hospital to Benefit Underserved Communities (Psilocybin Alpha)

  • Academic Centers Start to Take Psychedelics Seriously (Medpage Today)

  • Psychedelics and Mysticism: The Debate Continues (Psychedelic Science Review)

  • Psychedelics, Cognition, and Sleep Disorders (Truffle Report)

  • Is Psychedelic Research Funding Starting to Shift? (Medpage Today)

  • Revive Therapeutics Files for ODD Designation for Bucillamine Treatment Targeting Rare Liver Disorders, COVID-19 (Truffle Report)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.19.21

Cannabis

  • U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

  • Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

  • Brazil is on The Brink of Medical Cannabis Change (High Times)

  • Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

  • Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

  • New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

  • Straws Lined with THC Could Transform Edibles Industry (High Times)

  • Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

  • New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

  • Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

  • Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

  • Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

  • Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

  • Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

  • Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

  • MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

  • Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

  • Is LSD Safe - Latest Research Findings (Drug Science)

  • The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

  • Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

  • NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

  • Magic Mushrooms, A Love Story (The New Yorker)

  • PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

  • Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

  • TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

  • Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

  • Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

  • World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

  • Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

  • Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

  • Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

  • Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

  • Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

  • Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

  • New Psychedelic Molecules: What’s in Development? (Truffle Report)

  • New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

  • Researchers train computers to predict the next designer drugs (ScienceDaily)

  • BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

  • Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

  • Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

  • Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

  • Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

  • Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

  • Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

  • "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

  • Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

  • Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

  • New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

  • Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

  • Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

  • Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

  • Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

  • Three Decades of Drug Policy Reform Work (Open Society Foundations)

  • A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

  • Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

  • A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

  • The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

  • Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

  • CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

  • MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

  • Letting people test their drugs will reduce the number of needless deaths (The Independent)

  • The History of Psychedelics: An ancient tradition (Canex)

  • MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.